Showing results (281-290 of 288) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 288 results.
Annals of the Rheumatic Diseases|September 15, 2022
2021 EULAR points to consider to support people with rheumatic and musculoskeletal diseases to participate in healthy and sustainable paid workAnnelies Boonen, Casper Webers, Maarten Butink, et al.
Microbiology Spectrum|September 15, 2021
Saliva SARS-CoV-2 Antibody Prevalence in ChildrenMaya W Keuning, Marloes Grobben, Anne-Elise C de Groen, et al.
European Journal of Pediatrics|April 15, 2024
Prospective multicenter evaluation of adherence to the Dutch guideline for children aged 0-16 years with fever without a source-febrile illness in children (FINCH) studyMaya W Keuning, Nikki N Klarenbeek, Hidde J Bout, et al.
The Lancet. Global Health|May 1, 2022
Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burdenBronner P Gonçalves, Simon R Procter, Proma Paul, et al.
Annals of the Rheumatic Diseases|September 26, 2009
Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trialRobert B M Landewé, Jos G A Houbiers, Filip Van den Bosch, et al.
Annals of the Rheumatic Diseases|July 23, 2013
Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiativeFrancisca Sivera, Mariano Andrés, Loreto Carmona, et al.
Eclinicalmedicine|August 20, 2025
Safety and effectiveness of the early-onset sepsis calculator to reduce antibiotic exposure in at-risk newborns: a cluster-randomised controlled trialBo M van der Weijden, Sanne W C M Janssen, Marijke C van der Weide, et al.
Annals of the Rheumatic Diseases|May 7, 2010
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugsJosef S Smolen, Robert Landewé, Ferdinand C Breedveld, et al.
Pageof 29